148 related articles for article (PubMed ID: 27816025)
1. Leptin, obesity and breast cancer: progress to understanding the molecular connections.
Barone I; Giordano C; Bonofiglio D; Andò S; Catalano S
Curr Opin Pharmacol; 2016 Dec; 31():83-89. PubMed ID: 27816025
[TBL] [Abstract][Full Text] [Related]
2. Obesity and cancer--mechanisms underlying tumour progression and recurrence.
Park J; Morley TS; Kim M; Clegg DJ; Scherer PE
Nat Rev Endocrinol; 2014 Aug; 10(8):455-465. PubMed ID: 24935119
[TBL] [Abstract][Full Text] [Related]
3. The role of three-dimensional in vitro models in modelling the inflammatory microenvironment associated with obesity in breast cancer.
Blyth RRR; Birts CN; Beers SA
Breast Cancer Res; 2023 Sep; 25(1):104. PubMed ID: 37697381
[TBL] [Abstract][Full Text] [Related]
4. The role of immune dysfunction in obesity-associated cancer risk, progression, and metastasis.
Kulkarni A; Bowers LW
Cell Mol Life Sci; 2021 Apr; 78(7):3423-3442. PubMed ID: 33464384
[TBL] [Abstract][Full Text] [Related]
5. An Overview of Recent Findings that Shed Light on the Connection between Fat and Cancer.
Pandit P; Shirke C; Bhatia N; Godad A; Belemkar S; Patel J; Zine S
Endocr Metab Immune Disord Drug Targets; 2024; 24(2):178-193. PubMed ID: 37489790
[TBL] [Abstract][Full Text] [Related]
6. Too Much, Too Little, or Just Right? Obesity and Dosing of Targeted Therapies in Breast Cancer.
Cao C; Ligibel JA
J Clin Oncol; 2023 Nov; 41(33):5090-5092. PubMed ID: 37797274
[No Abstract] [Full Text] [Related]
7. From obesity to cancer: a review on proposed mechanisms.
Tahergorabi Z; Khazaei M; Moodi M; Chamani E
Cell Biochem Funct; 2016 Dec; 34(8):533-545. PubMed ID: 27859423
[TBL] [Abstract][Full Text] [Related]
8. Inflammation, dysregulated metabolism and aromatase in obesity and breast cancer.
Zahid H; Simpson ER; Brown KA
Curr Opin Pharmacol; 2016 Dec; 31():90-96. PubMed ID: 27875786
[TBL] [Abstract][Full Text] [Related]
9. Role of inflammation in obesity-related breast cancer.
Crespi E; Bottai G; Santarpia L
Curr Opin Pharmacol; 2016 Dec; 31():114-122. PubMed ID: 27889687
[TBL] [Abstract][Full Text] [Related]
10. Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.
Picon-Ruiz M; Morata-Tarifa C; Valle-Goffin JJ; Friedman ER; Slingerland JM
CA Cancer J Clin; 2017 Sep; 67(5):378-397. PubMed ID: 28763097
[TBL] [Abstract][Full Text] [Related]
11. Obesity and breast cancer: risk, outcomes, and future considerations.
Yung RL; Ligibel JA
Clin Adv Hematol Oncol; 2016 Oct; 14(10):790-797. PubMed ID: 27930630
[TBL] [Abstract][Full Text] [Related]
12. Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer.
Mishra AK; Parish CR; Wong ML; Licinio J; Blackburn AC
PLoS One; 2017; 12(5):e0178454. PubMed ID: 28542577
[TBL] [Abstract][Full Text] [Related]
13. Leptin signaling and cancer chemoresistance: Perspectives.
Candelaria PV; Rampoldi A; Harbuzariu A; Gonzalez-Perez RR
World J Clin Oncol; 2017 Apr; 8(2):106-119. PubMed ID: 28439492
[TBL] [Abstract][Full Text] [Related]
14. Moving forward with obesity research in breast cancer.
Lohmann AE; Goodwin PJ
Breast; 2017 Apr; 32():225-226. PubMed ID: 27863969
[No Abstract] [Full Text] [Related]
15. Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms.
Andò S; Gelsomino L; Panza S; Giordano C; Bonofiglio D; Barone I; Catalano S
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30634494
[TBL] [Abstract][Full Text] [Related]
16. Linkage Between Obesity Leptin and Breast Cancer.
Atoum MF; Alzoughool F; Al-Hourani H
Breast Cancer (Auckl); 2020; 14():1178223419898458. PubMed ID: 31975779
[TBL] [Abstract][Full Text] [Related]
17. Molecular Links between Central Obesity and Breast Cancer.
Zimta AA; Tigu AB; Muntean M; Cenariu D; Slaby O; Berindan-Neagoe I
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661891
[No Abstract] [Full Text] [Related]
18. Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models.
Sabol RA; Bowles AC; Côté A; Wise R; O'Donnell B; Matossian MD; Hossain FM; Burks HE; Del Valle L; Miele L; Collins-Burow BM; Burow ME; Bunnell BA
Breast Cancer Res; 2019 May; 21(1):67. PubMed ID: 31118047
[TBL] [Abstract][Full Text] [Related]
19. Signaling Pathways Induced by Leptin during Epithelial⁻Mesenchymal Transition in Breast Cancer.
Olea-Flores M; Juárez-Cruz JC; Mendoza-Catalán MA; Padilla-Benavides T; Navarro-Tito N
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404206
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer.
Mauro L; Naimo GD; Gelsomino L; Malivindi R; Bruno L; Pellegrino M; Tarallo R; Memoli D; Weisz A; Panno ML; Andò S
FASEB J; 2018 Aug; 32(8):4343-4355. PubMed ID: 29513571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
